AI assistant
Sending…
Medtronic plc — Director's Dealing 2025
Jan 27, 2025
29841_dirs_2025-01-27_bea5cc44-9b00-4d18-b731-6e978a108490.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Medtronic plc (MDT)
CIK: 0001613103
Period of Report: 2025-01-24
Reporting Person: Wall Brett A. (EVP & Pres Neuroscience)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-01-24 | Ordinary Shares | M | 12437 | $78 | Acquired | 53416 | Direct |
| 2025-01-24 | Ordinary Shares | S | 12437 | $90 | Disposed | 40979 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-01-24 | Stock Option (Right to Buy) | $78 | M | 12437 | Disposed | 2025-08-03 | Ordinary Shares (12437) | Direct |
Footnotes
F1: Includes 271 shares acquired through dividend reinvestment since the last report filed by the reporting person.
More from Medtronic plc
Report Publication Announcement
2026
Jun 3
Regulatory Filings
2026
May 28
Board/Management Information
2026
May 18
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Feb 26
Director's Dealing
2026
Feb 24
Interim / Quarterly Report
2026
Feb 24
Earnings Release
2026
Feb 17
Director's Dealing
2026
Feb 2
Director's Dealing
2026
Jan 29